Pharmacogenetic and Antidepressant Treatment in Elderly
NCT ID: NCT02856477
Last Updated: 2016-08-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
28 participants
INTERVENTIONAL
2007-11-30
2016-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Therapeutic benefits are evaluated through the enhancement of efficiency, decrease of the action time and the after effects.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cytochrome P450-2D6 Screening Among Elderly Using Antidepressants (CYSCE)
NCT01778907
Medication Treatment for Depression in Nursing Home Residents
NCT00076622
Oral Fluency and the Response to Antidepressant Therapy in the Elderly With a Unipolar Depressive Episode
NCT03227133
Rhythm and Depression
NCT02857036
Safety, Tolerability and Efficacy of the Transdermal System in Elderly Subjects With Major Depression
NCT00285766
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
adapted treatment
the treatment dose is adapted to the metabolic capacity of the patient. intervention: urine analysis
urine analysis
a sample of urine is collected during 8 hours.
non-adaptated treatment
the treatment dose is adapted to the metabolic capacity of the patient. intervention: urine analysis
urine analysis
a sample of urine is collected during 8 hours.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
urine analysis
a sample of urine is collected during 8 hours.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* antidepressant treatment
Exclusion Criteria
* other psychiatric disorder
* kidney failure
* liver failure mini mental State Examination (MMSE)\<18
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire de Besancon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
pierre Vandel, MD PhD
Role: PRINCIPAL_INVESTIGATOR
Centre Hospitalier Universitaire de Besancon
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU Besancon
Besançon, Doubs, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
R/2007/32
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.